MDMA (Ecstasy) Test Evidence
Has Caused a False Positive
3,4-Methylenedioxy-alpha-pyrrolidinohexanophenone
Source Pasi et al., J Appl Lab Med 2026
What It Found
- In a study of this synthetic cathinone, investigators found evidence that metabolites may trigger the ecstasy screen.
- Adding the unchanged drug did not itself produce a positive.
Keep in Mind
- This is a nonprescription psychoactive-substance exposure.
- The specific reactive metabolite was not established.
Test Studied
- Syva EMIT II Plus Ecstasy
Fenofibrate
Source Bugier et al., Mil Med 2016
What It Found
- In a French military cohort, 22 of 15,169 urine screens were positive for MDMA.
- GC-MS confirmed none.
- The investigators identified fenofibric acid, a fenofibrate metabolite, in the investigation.
Keep in Mind
- The cohort was not limited to people taking fenofibrate and cannot estimate their individual risk.
Source Quesada et al., J Anal Toxicol 2015
Keep in Mind
- In a separate case, the measured free metabolite alone did not fully explain the signal.
All 3 sources Bugier et al., Mil Med 2016 Quesada et al., J Anal Toxicol 2015 Kaplan et al., Ther Drug Monit 2012
Test Studied
- DRI Ecstasy
Labetalol
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- A clinical-record signal prompted laboratory testing.
- Urine spiked with labetalol at 200 micrograms/mL produced a positive MDMA result on this cup.
Keep in Mind
- The experiment used added parent drug.
- This concentration is not a patient dose or a clinical risk estimate.
Test Studied
- Alere Integrated E-Z Split Key Cup II, MDMA channel
Mebeverine
Source Moncef et al., Acta Clin Belg 2026
What It Found
- Three treated patients screened positive while GC-MS detected neither MDMA nor MDA.
- Controlled administration reproduced positive screens.
- Mebeverine O-desmethyl-butanol was consistently present.
Keep in Mind
- Parent mebeverine spiked at the tested concentration was negative.
- The evidence implicates a metabolite.
Test Studied
- 12-panel lateral-flow urine test, MDMA cutoff 500 ng/mL
Also cited: Bedussi et al., Br J Clin Pharmacol 2021
Metoprolol
Source Leclercq et al., J Anal Toxicol 2020
What It Found
- After metoprolol poisoning, the reported MDMA results did not confirm by GC-MS.
- Metoprolol added to urine also triggered the MDMA screen.
Keep in Mind
- The two tested metabolites only reacted with the amphetamine screen.
- The MDMA evidence concerns parent metoprolol and poisoning.
Test Studied
- Abbott MULTIGENT Ecstasy
Stiripentol
Source Magny et al., Ann Biol Clin (Paris) 2025
What It Found
- In a child receiving stiripentol, two MDMA-positive screens failed GC-MS confirmation.
- Laboratory testing reproduced the reaction with stiripentol.
- The third sample, at a lower drug concentration, screened negative.
Keep in Mind
- This report concerns the kit and three samples from the same child.
Test Studied
- Automated urine ecstasy immunoassay
Trazodone
Source Logan et al., J Anal Toxicol 2010
What It Found
- Patient samples positive on the ecstasy screen contained trazodone and mCPP.
- LC-MS/MS found no MDMA.
- Tests with reference material showed that both trazodone and mCPP could trigger the assay.
Keep in Mind
- This is evidence for an MDMA-specific assay.
Test Studied
- EMIT II Ecstasy
Both sources Logan et al., J Anal Toxicol 2010 Marin et al., J Anal Toxicol 2016
Keep in Mind
- The response on other kits can differ.
Bupropion
Source Marin et al., J Anal Toxicol 2016
What It Found
- A bupropion metabolite, erythrohydrobupropion, triggered a positive MDMA result at 10.5 micrograms/mL in synthetic urine.
Keep in Mind
- This experiment does not establish how often MDMA screens turn positive during treatment.
Test Studied
- Syva EMIT II Plus Ecstasy, 500 ng/mL cutoff
Fenofibric acid
Both sources Bugier et al., Mil Med 2016 Quesada et al., J Anal Toxicol 2015
What It Found
- Testing identified fenofibric acid as a cross-reactant in a study prompted by patients taking fenofibrate.
- Fenofibric acid is also an active medicinal ingredient.
Keep in Mind
- The clinical cases cited involved fenofibrate treatment.
- Direct case evidence for each fenofibric acid formulation was not established.
Test Studied
- DRI Ecstasy
Depends on the Brand of Test
Meta-chlorophenylpiperazine
Both sources Regester et al., J Anal Toxicol 2015 Logan et al., J Anal Toxicol 2010
What It Found
- The two ecstasy assays disagreed.
Keep in Mind
- Whether m-CPP turns an ecstasy screen positive depends on which assay the lab used.
Source Regester et al., J Anal Toxicol 2015
What It Found
- On the Microgenics DRI Ecstasy assay, m-CPP added to drug-free urine stayed negative at 100 µg/mL.
Keep in Mind
- The laboratory concentrations do not predict a result in a patient.
Test Studied
- Microgenics DRI Ecstasy on a Roche/Hitachi Modular P
Source Logan et al., J Anal Toxicol 2010
What It Found
- On the EMIT II Ecstasy assay, an m-CPP standard cross-reacted, and urine from patients taking trazodone that screened positive contained trazodone and m-CPP with no MDMA by LC-MS/MS.
Test Studied
- Siemens/Syva EMIT II Ecstasy
A Related Drug the Test Picks Up
4-CAP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-CAP challenge, Microgenics DRI Ecstasy gave a positive result at 20 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-Fluoroamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Fluoroamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 37.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-Fluoromethamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Fluoromethamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 11 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-Methylamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methylamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-Methylthioamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methylthioamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-APB
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APB challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-APDB
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APDB challenge, Microgenics DRI Ecstasy gave a positive result at 0.2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-APDI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APDI challenge, Microgenics DRI Ecstasy gave a positive result at 20 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
6-APB
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 6-APB challenge, Microgenics DRI Ecstasy gave a positive result at 16 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
BDB
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 33% cross-reactivity for BDB on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 15
Butylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Butylone challenge, Microgenics DRI Ecstasy gave a positive result at 60 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Ethylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Ethylone challenge, Microgenics DRI Ecstasy gave a positive result at 96 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Eutylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Eutylone challenge, Microgenics DRI Ecstasy gave a positive result at 55 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MBDB
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 25% cross-reactivity for MBDB on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 13
MDA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 56% cross-reactivity for MDA on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 14
MDEA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 83% cross-reactivity for MDEA on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 16
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDEA challenge, Microgenics DRI Ecstasy gave a positive result at 0.4 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015
Keep in Mind
- The result depends on the reagent, the cutoff and the concentration in the specimen.
MDPPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDPPP challenge, Microgenics DRI Ecstasy gave a positive result at 95 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methedrone challenge, Microgenics DRI Ecstasy gave a positive result at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methylone challenge, Microgenics DRI Ecstasy gave a positive result at 80 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
PMA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 11% cross-reactivity for PMA on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 18
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the PMA challenge, Microgenics DRI Ecstasy gave a positive result at 5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015
Keep in Mind
- The result depends on the reagent, the cutoff and the concentration in the specimen.
PMMA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 29% cross-reactivity for PMMA on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 17
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the PMMA challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015
Keep in Mind
- The result depends on the reagent, the cutoff and the concentration in the specimen.
The Test Is Made to Find It
MDMA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 100% cross-reactivity for MDMA on the Microgenics DRI screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
- MDMA, row 12
Tested: No False Positive Found
2,5-Dimethoxyamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2,5-Dimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2,5-Dimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
2-Aminoindane
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2-Aminoindane challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2-DPMP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2-DPMP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
25B-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25B-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
25C-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25C-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
25I-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25I-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-B
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-B challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-C
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-C challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-E
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-E challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-I
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-I challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-N
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-N did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
2C-T
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
2C-T-13
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
2C-T-17
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
2C-T-2
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-2 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
2C-T-4
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-4 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
2C-T-5
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
2C-T-7
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-7 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
3,4,5-Trimethoxyamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3,4,5-Trimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
3,4-Dimethylmethcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3,4-Dimethylmethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
3-Trifluoromethylphenylpiperazine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-EEC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-EEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-HO-DET
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-HO-DET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-MEC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-MePPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MePPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-Methoxyphencyclidine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methoxyphencyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-MPBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
4-TFMPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-IAI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-IAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-IT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-IT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-MeO-AMT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-AMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-MeO-DALT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DALT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-MeO-DiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-MeO-DMT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
5-MeO-MiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-MiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The study found no cup interference from Acetaminophen at 1,000 ng/mL in drug-free urine.
Keep in Mind
- The finding is limited to the device configuration and concentration tested.
Test Studied
- NexScreen urine MDMA strip
ALEPH
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
ALEPH-13
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
ALEPH-17
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
ALEPH-2
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
ALEPH-5
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
ALEPH-7
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Alpha-methyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-methyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Alpha-PBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Alpha-PPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Alpha-PVP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PVP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Alpha-PVT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PVT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Benocyclidine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benocyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Benzedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benzedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Benzylpiperazine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
BOB
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOB did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
BOD
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
BOH
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
BOHD
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOHD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Bromo-DragonFLY
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Bromo-DragonFLY challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Buphedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Buphedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Cathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Cathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
D2PM
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the D2PM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The study found no cup interference from Dextromethorphan at 1,000 ng/mL in drug-free urine.
Keep in Mind
- The finding is limited to the device configuration and concentration tested.
Test Studied
- NexScreen urine MDMA strip
Dibenzylpiperazine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dibenzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Diethylpropion
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Diethylpropion challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Dimethylamylamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethylamylamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Dimethylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Dimethyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Diphenhydramine
Source Lin et al., J Anal Toxicol 2013
What It Found
- The study found no cup interference from Diphenhydramine at 1,000 ng/mL in drug-free urine.
Keep in Mind
- The finding is limited to the device configuration and concentration tested.
Test Studied
- NexScreen urine MDMA strip
Dipropyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dipropyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
DiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
DOB
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOB challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
DOC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOC did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
DOET
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOET did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
DOI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOI did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
- Different antibody formulations can give different results.
DOM
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
DON
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DON did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
DOPR
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOPR did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
Escaline
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Escaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Ethcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Ethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Flephedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Flephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MDAI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MDBZ
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDBZ did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
MDCPM
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDCPM did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
MDIP
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDIP did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
MDPBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Mephedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Mephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The study found no cup interference from Meprobamate at 1,000 ng/mL in drug-free urine.
Keep in Mind
- The finding is limited to the device configuration and concentration tested.
Test Studied
- NexScreen urine MDMA strip
Mescaline
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Mescaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methiopropamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methiopropamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methoxetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methoxetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Methylenedioxypyrovalerone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methylenedioxypyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MOPPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MOPPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MPHP (study designation)
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MPHP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
MT-45
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MT-45 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
N,N-Dimethylcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the N,N-Dimethylcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Naphyrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Naphyrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Pentedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pentedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Pentylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pentylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
Pyrovalerone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy
TMA-2
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
TMA-3
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-3 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
TMA-6
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-6 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Methamphetamine/MDMA urine ELISA
WIN 35,428
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the WIN 35,428 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy